Literature DB >> 12072439

Phosphatidylinositol 3-kinase activity negatively regulates stability of cyclooxygenase 2 mRNA.

Martha M Monick1, Pamela K Robeff, Noah S Butler, Dawn M Flaherty, A Brent Carter, Michael W Peterson, Gary W Hunninghake.   

Abstract

Human alveolar macrophages have both lipopolysaccharide (LPS)-induced and constitutive phosphatidylinositol 3-kinase (PI3K) activity. We observed that blocking PI3K activity increased release of prostaglandin E2 after LPS exposure, and increasing PI3K activity (interleukin-13) decreased release of prostaglandin E2 after LPS exposure. This was not because of an effect of PI3K on phospholipase 2 activity. PI3K inhibition resulted in an increase in cyclooxygenase 2 (COX2) protein, mRNA, and mRNA stability. PI3K negatively regulated activation of the p38 pathway (p38, MKK3/6, and MAPKAP2), and an active p38 was necessary for COX2 production. The data suggest that PI3K inhibition of p38 modulates COX2 expression via destabilization of LPS-induced COX2 mRNA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12072439     DOI: 10.1074/jbc.M203218200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  B-cell adaptor for PI3K (BCAP) negatively regulates Toll-like receptor signaling through activation of PI3K.

Authors:  Minjian Ni; Alexander W MacFarlane; Michelle Toft; Clifford A Lowell; Kerry S Campbell; Jessica A Hamerman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-20       Impact factor: 11.205

Review 2.  Macrophage polarization: the link between inflammation and related diseases.

Authors:  Samina Bashir; Yadhu Sharma; Asif Elahi; Farah Khan
Journal:  Inflamm Res       Date:  2016-01       Impact factor: 4.575

Review 3.  Negative regulation of TLR signaling in myeloid cells--implications for autoimmune diseases.

Authors:  Jessica A Hamerman; Jessica Pottle; Minjian Ni; Yantao He; Zhong-Yin Zhang; Jane H Buckner
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

4.  Selenomethionine inhibits IL-1β inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes.

Authors:  A W M Cheng; T V Stabler; M Bolognesi; V B Kraus
Journal:  Osteoarthritis Cartilage       Date:  2010-10-28       Impact factor: 6.576

Review 5.  New players in TLR-mediated innate immunity: PI3K and small Rho GTPases.

Authors:  Monica Ruse; Ulla G Knaus
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

6.  TLR4/MyD88/PI3K interactions regulate TLR4 signaling.

Authors:  Michelle H W Laird; Sang Hoon Rhee; Darren J Perkins; Andrei E Medvedev; Wenji Piao; Matthew J Fenton; Stefanie N Vogel
Journal:  J Leukoc Biol       Date:  2009-03-16       Impact factor: 4.962

7.  Molecular markers of preterm labor in the choriodecidua.

Authors:  Renu Shankar; Matthew P Johnson; Nicholas A Williamson; Fiona Cullinane; Anthony W Purcell; Eric K Moses; Shaun P Brennecke
Journal:  Reprod Sci       Date:  2009-12-15       Impact factor: 3.060

8.  Specific engagement of TLR4 or TLR3 does not lead to IFN-beta-mediated innate signal amplification and STAT1 phosphorylation in resident murine alveolar macrophages.

Authors:  Antonello Punturieri; Rebecca S Alviani; Timothy Polak; Phil Copper; Joanne Sonstein; Jeffrey L Curtis
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

9.  Inhibition of cyclooxygenase-1 and cyclooxygenase-2 impairs Trypanosoma cruzi entry into cardiac cells and promotes differential modulation of the inflammatory response.

Authors:  Aparecida D Malvezi; Carolina Panis; Rosiane V da Silva; Rafael Carvalho de Freitas; Maria I Lovo-Martins; Vera L H Tatakihara; Nágela G Zanluqui; Edecio Cunha Neto; Samuel Goldenberg; Juliano Bordignon; Sueli F Yamada-Ogatta; Marli C Martins-Pinge; Rubens Cecchini; Phileno Pinge-Filho
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

10.  2,2',4,4'-Tetrachlorobiphenyl upregulates cyclooxygenase-2 in HL-60 cells via p38 mitogen-activated protein kinase and NF-kappaB.

Authors:  Steven A Bezdecny; Peer Karmaus; Robert A Roth; Patricia E Ganey
Journal:  Toxicol Appl Pharmacol       Date:  2007-03-30       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.